New England Journal of Medicine

Print ISSN
0028-4793
Electronic ISSN
1533-4406
Impact factor
53.486
Publisher
Proquest
URL
http://www.nejm.org/loi/nejm
Usage rank
17
Article count
74857
Free count
10006
Free percentage
0.133668
PDFs via platforms
Gale, Highwire, Ovid, CSA, and Proquest

  1. This Week in the Journal
    Author(s) unavailable

    New England Journal of Medicine 372(19):1790 (2015)

  2. This Week in the Journal
    Author(s) unavailable

    New England Journal of Medicine 372(18):1688 (2015)

  3. Controversies in the Treatment of Early-Stage Hodgkin's Lymphoma

    New England Journal of Medicine 372(17):1667 (2015) PMID 25901431

    Hodgkin’s lymphoma affects about 8000 patients a year in the United States, and with available therapies, about 7000 of them will be cured. Although room for improvement still exists, recent clinical research has focused on determining how little therapy can be given to maintain the cu...
  4. Use of Cell-free DNA to Screen for Down's Syndrome

    New England Journal of Medicine 372(17):1666 (2015) PMID 25830324

    Standard prenatal screening for trisomy 21 (Down's syndrome) is based on a combination of maternal age, maternal serum biomarkers, and fetal ultrasonographic findings. Such screening can identify 70 to 90% of fetuses with trisomy 21 with a false positive rate of 2 to 5%.1 Screening tha...
  5. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
    Author(s) unavailable

    New England Journal of Medicine 372(17):1677 (2015) PMID 25901443

    Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines Special Article, N Engl J Med 2015;372:447-455. In Table 3 (page 452), the unit given below the “Change in Cardiovascular Costs, as Compared with Status Quo” column head should have been “millions of $,” rather tha...
  6. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    New England Journal of Medicine 372(17):1672 (2015) PMID 25901437

    To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) by Francis et al. (Jan. 29 issue)1 are presented as practice changing. However, we are concerned about the emphasis given to the receipt of adjuvant chemotherapy — which was considered as a proxy for a disea...
  7. Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    New England Journal of Medicine 372(17):1670 (2015) PMID 25901432

    To the Editor: Vannucchi et al. (Jan. 29 issue)1 report that ruxolitinib was superior to standard therapy in patients with polycythemia vera who had an inadequate response to or had unacceptable side effects from hydroxyurea. The primary end point included hematocrit control and a redu...
  8. Factor XI Antisense Oligonucleotide for Venous Thrombosis

    New England Journal of Medicine 372(17):1671 (2015) PMID 25901434

    To the Editor: I would caution against concluding, on the basis of the study by Büller et al. (Jan. 15 issue),1 that reducing factor XI levels attenuates the risk of thrombosis without increasing the risk of bleeding. Factor XI deficiency selectively increases the risk of bleeding in t...
  9. A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
    Author(s) unavailable

    New England Journal of Medicine 372(17):1677 (2015) PMID 25901444

    A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis Original Article, N Engl J Med 2014;371:1588-1598. In Table 2 (page 1594), the values given in the Control Group column in the third row from the bottom of the table should have been 53/676 (7.8), rather than 753/67...
  10. This Week in the Journal
    Author(s) unavailable

    New England Journal of Medicine 372(17):1588 (2015)

  11. Case 3-2015: A Woman with Abdominal Pain, Dyspnea, and Diplopia

    New England Journal of Medicine 372(17):1674 (2015) PMID 25901441

    To the Editor: In the case of a 60-year-old woman with abdominal pain, dyspnea, and diplopia who received a diagnosis of botulism (Jan. 22 issue),1 one of the differential diagnoses was the Guillain–Barré syndrome. We would like to point out that variants of the Guillain–Barré syndrome...
  12. Treatment of Ebola

    New England Journal of Medicine 372(17):1673 (2015) PMID 25901439

    To the Editor: We were struck by the similarity of transient vascular leak in Ebola virus disease (EVD), as reported by Lyon et al. (Dec. 18 issue),1 with that which occurs in dengue. When severe dengue was first described, uncorrected hypovolemia often led to shock, hemorrhage, and de...
  13. New Agents for Hyperkalemia

    New England Journal of Medicine 372(16):1569 (2015) PMID 25875263

    To the Editor: In the study by Weir et al. (Jan. 15 issue),1 the low baseline rate of use of loop diuretics (32% of patients) is noteworthy and might limit the clinical applicability of their finding that patiromer was effective in reducing hyperkalemia in patients with chronic kidney ...
  14. Trends in Opioid Analgesic Abuse and Mortality in the United States

    New England Journal of Medicine 372(16):1572 (2015) PMID 25875268

    To the Editor: Dart et al. (Jan. 15 issue)1 conclude that the United States may be making progress in controlling the abuse of opioid analgesics. However, they understate the increasing problem of opioid-associated deaths, especially those related to heroin. First, the death ...
  15. This Week in the Journal
    Author(s) unavailable

    New England Journal of Medicine 372(16):1488 (2015)

  16. Case 12-2015: A Newborn Boy with Respiratory Distress, Lethargy, and Hypernatremia

    New England Journal of Medicine 372(16):1550 (2015) PMID 25875261

    A newborn boy was admitted to the hospital because of respiratory distress and hypotension. At delivery, meconium was suctioned from the airway. Respiration and blood pressure improved after intervention, but lethargy and myoclonus developed. Presentation of Case Dr...
  17. Loss of Fingerprints

    New England Journal of Medicine 372(16):e22 (2015) PMID 25875278

    A 65-year-old woman with stage IV triple-negative breast cancer (a tumor characterized by the lack of estrogen and progesterone receptors and expression of human epidermal growth factor receptor type 2 [HER2]) presented after being denied authorization to perform a banking transaction ...
  18. Sodium Zirconium Cyclosilicate for Urgent Therapy of Severe Hyperkalemia

    New England Journal of Medicine 372(16):1577 (2015) PMID 25875277

    The authors of this letter report that in patients with severe hyperkalemia at baseline, treatment with a single dose of sodium zirconium cyclosilicate was associated a rapid and significant reduction in potassium as early as 1 hour after administration. To the Editor: Severe...
  19. Lowering LDL Cholesterol Is Good, but How and in Whom?

    New England Journal of Medicine 372(16):1564 (2015) PMID 25773740

    Genetic findings reported approximately 9 years ago in the Journal indicated that rare sequence variants in the gene encoding proprotein convertase subtilisin–kexin type 9 serine protease (PCSK9) were associated with significantly lower long-term plasma levels of low-density lipoprotei...
  20. More on Hidden Formaldehyde in E-Cigarette Aerosols

    New England Journal of Medicine 372(16):1575 (2015) PMID 25875273

    To the Editor: The data presented by Jensen et al. (Jan. 22 issue)1 in their recent letter to the Editor do not support their conclusion that e-cigarette use presents a likely risk of excessive exposure to formaldehyde. The 5-V puff topography used by Jensen et al. appears to have over...